Baidu
map

化学药物中亚硝胺类杂质研究技术指导原则(试行)

2020-06-02 国家药品监督管理局药品审评中心(CDE) CDE

为了保证药品的安全和质量可控,实现有效的风险控制,在国家药品监督管理局的部署下,药审中心组织制定了《化学药物中亚硝胺类杂质研究技术指导原则(试行)》(见附件),根据《国家药监局综合司关于印发药品技术指

中文标题:

化学药物中亚硝胺类杂质研究技术指导原则(试行)

发布日期:

2020-06-02

简要介绍:

为了保证药品的安全和质量可控,实现有效的风险控制,在国家药品监督管理局的部署下,药审中心组织制定了《化学药物中亚硝胺类杂质研究技术指导原则(试行)》(见附件),根据《国家药监局综合司关于印发药品技术指导原则发布程序的通知》(药监综药管〔2020〕9号)要求,经国家药品监督管理局审核同意,现予发布。
       特此通告。
                                                                                                                           国家药品监督管理局药品审评中心
                                                                                                                                         2020年5月8日

相关资料下载:
[AttachmentFileName(sort=1, fileName=66.docx)] GetToolGuiderByIdResponse(projectId=1, id=dae411c0021168ff, title=化学药物中亚硝胺类杂质研究技术指导原则(试行), enTitle=, guiderFrom=CDE, authorId=0, author=, summary=为了保证药品的安全和质量可控,实现有效的风险控制,在国家药品监督管理局的部署下,药审中心组织制定了《化学药物中亚硝胺类杂质研究技术指导原则(试行)》(见附件),根据《国家药监局综合司关于印发药品技术指, cover=, journalId=0, articlesId=null, associationId=1936, associationName=国家药品监督管理局药品审评中心(CDE), associationIntro=国家药品监督管理局药品审评中心(CDE), copyright=0, guiderPublishedTime=Tue Jun 02 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<p>为了保证药品的安全和质量可控,实现有效的风险控制,在国家药品监督管理局的部署下,药审中心组织制定了《化学药物中亚硝胺类杂质研究技术指导原则(试行)》(见附件),根据《国家药监局综合司关于印发药品技术指导原则发布程序的通知》(药监综药管〔2020〕9号)要求,经国家药品监督管理局审核同意,现予发布。<br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 特此通告。<br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 国家药品监督管理局药品审评中心<br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2020年5月8日</p>, tagList=[TagDto(tagId=33294, tagName=化学药物)], categoryList=[CategoryDto(categoryId=11, categoryName=药械, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指导原则, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=20, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=1807, appHits=19, showAppHits=0, pcHits=377, showPcHits=1788, likes=0, shares=4, comments=6, approvalStatus=1, publishedTime=Sun Jun 27 10:08:21 CST 2021, publishedTimeString=2020-06-02, pcVisible=1, appVisible=1, editorId=4754896, editor=fbzhang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=fbzhang, createdTime=Sun Jun 27 10:08:17 CST 2021, updatedBy=4754896, updatedName=fbzhang, updatedTime=Sat Dec 30 14:35:56 CST 2023, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=66.docx)])
66.docx
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=996694, encodeId=37c69966946f, content=理学, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62a85535130, createdName=ms3000001999514966, createdTime=Tue Jul 06 09:10:50 CST 2021, time=2021-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977587, encodeId=10fc9e7587db, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210628/39fb2df92f364c8b8844c94450d70f1b/4696e00e60614453b7aa1f3f66663d7f.jpg, createdBy=083b5535857, createdName=shock, createdTime=Mon Jun 28 15:09:50 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977442, encodeId=3f7b9e7442c0, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e185535455, createdName=ms1000001603797122, createdTime=Sun Jun 27 23:16:16 CST 2021, time=2021-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977297, encodeId=42619e729789, content=赞👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210627/bfd172f9945c40638fb6690b2055104f/11dc30fbfd9b43328a224b891e909299.jpg, createdBy=324f5523472, createdName=ms2550785022369385, createdTime=Sun Jun 27 14:14:39 CST 2021, time=2021-06-27, status=1, ipAttribution=)]
    2021-07-06 ms3000001999514966

    理学

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=996694, encodeId=37c69966946f, content=理学, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62a85535130, createdName=ms3000001999514966, createdTime=Tue Jul 06 09:10:50 CST 2021, time=2021-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977587, encodeId=10fc9e7587db, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210628/39fb2df92f364c8b8844c94450d70f1b/4696e00e60614453b7aa1f3f66663d7f.jpg, createdBy=083b5535857, createdName=shock, createdTime=Mon Jun 28 15:09:50 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977442, encodeId=3f7b9e7442c0, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e185535455, createdName=ms1000001603797122, createdTime=Sun Jun 27 23:16:16 CST 2021, time=2021-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977297, encodeId=42619e729789, content=赞👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210627/bfd172f9945c40638fb6690b2055104f/11dc30fbfd9b43328a224b891e909299.jpg, createdBy=324f5523472, createdName=ms2550785022369385, createdTime=Sun Jun 27 14:14:39 CST 2021, time=2021-06-27, status=1, ipAttribution=)]
    2021-06-28 shock

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=996694, encodeId=37c69966946f, content=理学, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62a85535130, createdName=ms3000001999514966, createdTime=Tue Jul 06 09:10:50 CST 2021, time=2021-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977587, encodeId=10fc9e7587db, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210628/39fb2df92f364c8b8844c94450d70f1b/4696e00e60614453b7aa1f3f66663d7f.jpg, createdBy=083b5535857, createdName=shock, createdTime=Mon Jun 28 15:09:50 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977442, encodeId=3f7b9e7442c0, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e185535455, createdName=ms1000001603797122, createdTime=Sun Jun 27 23:16:16 CST 2021, time=2021-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977297, encodeId=42619e729789, content=赞👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210627/bfd172f9945c40638fb6690b2055104f/11dc30fbfd9b43328a224b891e909299.jpg, createdBy=324f5523472, createdName=ms2550785022369385, createdTime=Sun Jun 27 14:14:39 CST 2021, time=2021-06-27, status=1, ipAttribution=)]
    2021-06-27 ms1000001603797122

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=996694, encodeId=37c69966946f, content=理学, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62a85535130, createdName=ms3000001999514966, createdTime=Tue Jul 06 09:10:50 CST 2021, time=2021-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977587, encodeId=10fc9e7587db, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210628/39fb2df92f364c8b8844c94450d70f1b/4696e00e60614453b7aa1f3f66663d7f.jpg, createdBy=083b5535857, createdName=shock, createdTime=Mon Jun 28 15:09:50 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977442, encodeId=3f7b9e7442c0, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e185535455, createdName=ms1000001603797122, createdTime=Sun Jun 27 23:16:16 CST 2021, time=2021-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977297, encodeId=42619e729789, content=赞👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210627/bfd172f9945c40638fb6690b2055104f/11dc30fbfd9b43328a224b891e909299.jpg, createdBy=324f5523472, createdName=ms2550785022369385, createdTime=Sun Jun 27 14:14:39 CST 2021, time=2021-06-27, status=1, ipAttribution=)]
    2021-06-27 ms2550785022369385

    赞👍

    0

Baidu
map
Baidu
map
Baidu
map